Winsan (Chengdu) Medical Science And Technology Co (SHSE:600767) COGS-to-Revenue : 0.65 (As of Mar. 2023)

View and export this data going back to 1996. Start your Free Trial

What is Winsan (Chengdu) Medical Science And Technology Co COGS-to-Revenue?

Winsan (Chengdu) Medical Science And Technology Co's Cost of Goods Sold for the three months ended in Mar. 2023 was ¥4.36 Mil. Its Revenue for the three months ended in Mar. 2023 was ¥6.69 Mil.

Winsan (Chengdu) Medical Science And Technology Co's COGS to Revenue for the three months ended in Mar. 2023 was 0.65.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Winsan (Chengdu) Medical Science And Technology Co's Gross Margin % for the three months ended in Mar. 2023 was 34.72%.

Winsan (Chengdu) Medical Science And Technology Co COGS-to-Revenue Historical Data

The historical data trend for Winsan (Chengdu) Medical Science And Technology Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Winsan (Chengdu) Medical Science And Technology Co COGS-to-Revenue Chart

Winsan (Chengdu) Medical Science And Technology Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

COGS-to-Revenue

Get a 7-Day Free Trial

0.57

0.77

0.47

0.49

0.47

Winsan (Chengdu) Medical Science And Technology Co Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
COGS-to-Revenue	Get a 7-Day Free Trial															0.53	0.74	0.26	0.61	0.65

Winsan (Chengdu) Medical Science And Technology Co COGS-to-Revenue Calculation

Winsan (Chengdu) Medical Science And Technology Co's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	21.964	/	46.246
	=	0.47

Winsan (Chengdu) Medical Science And Technology Co's COGS to Revenue for the quarter that ended in Mar. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	4.364	/	6.685
	=	0.65

Winsan (Chengdu) Medical Science And Technology Co (SHSE:600767) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Winsan (Chengdu) Medical Science And Technology Co's Gross Margin % for the three months ended in Mar. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	4.364 / 6.685
	=	34.72 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Winsan (Chengdu) Medical Science And Technology Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Winsan (Chengdu) Medical Science And Technology Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Winsan (Chengdu) Medical Science And Technology Co (SHSE:600767) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Winsan (Chengdu) Medical Science And Technology Co Ltd (SHSE:600767) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 69 Dongfang Road, Unit 1102-1104, Pudong New District, Shanghai, CHN, 200120

Website

http://www.winsan.cn

Winsan (Chengdu) Medical Science And Technology Co Ltd are engaged in technology development, technical consultation, and technical services in the field of public health and regional medical information. The company projects include Lishui Population Health Information PPP project which includes home pension, chronic disease management, remote diagnosis and treatment, medical insurance, and pharmacy services. It covers approximately 33 public health service agencies, 23 public hospitals, 193 township health centers, and 983 health service stations.

Executives

Ma Wei Guo	Director
Hua En Min	senior management
Jiang Hui Fang	senior management
Guan Wen Lian	Director
Luo Yong Jian	Director
Zhou Luo Man	Supervisors
Qian Min Hua	Director
Wu Ai Qun	Supervisors
Liang Yong Xin	Director

Winsan (Chengdu) Medical Science And Technology Co (SHSE:600767) Headlines

No Headlines